Literature DB >> 6437751

Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation.

C M Burke, J Theodore, K D Dawkins, S A Yousem, N Blank, M E Billingham, A Van Kessel, S W Jamieson, P E Oyer, J C Baldwin.   

Abstract

Since March 1981, 19 patients have undergone heart-lung transplantation for end-stage pulmonary vascular disease, with 14 long-term survivors. In five of the survivors, obstructive airway disease has developed with the superimposition of a progressive restrictive ventilatory defect in three of them. None of these five patients showed a tendency for spontaneous improvement of flow rates. Biopsy and postmortem material was available in four of the five patients and showed obliterative bronchiolitis (OB) in three. A fourth patient showed clinical and physiologic data consistent with obliterative bronchitis, but histologic material was not available. Obstructive lung disease without restrictive features developed in a fifth patient, but no histologic evidence of OB was found at transbronchial biopsy. In addition to OB, recurrent lung infections were found in all patients, significant pleural fibrosis in two patients, and bronchiectasis in one patient. Despite these long-term sequelae of human heart-lung transplantation, ten of the 14 surviving patients are leading relatively normal lives.

Entities:  

Mesh:

Year:  1984        PMID: 6437751     DOI: 10.1378/chest.86.6.824

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  58 in total

1.  Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.

Authors:  C Ashley Finlen Copeland; Laurie D Snyder; David W Zaas; W Jackson Turbyfill; W Austin Davis; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

Review 2.  The current state of lung transplantation.

Authors:  J Dark; P A Corris
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

3.  Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.

Authors:  Hrishikesh S Kulkarni; Wida S Cherikh; Daniel C Chambers; Victoria C Garcia; Ramsey R Hachem; Daniel Kreisel; Varun Puri; Benjamin D Kozower; Derek E Byers; Chad A Witt; Jennifer Alexander-Brett; Patrick R Aguilar; Laneshia K Tague; Yuka Furuya; G Alec Patterson; Elbert P Trulock; Roger D Yusen
Journal:  J Heart Lung Transplant       Date:  2018-09-25       Impact factor: 10.247

Review 4.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

Review 5.  Regulatory T cell-mediated transplantation tolerance.

Authors:  Ankit Bharat; Ryan Courtney Fields; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 6.  Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.

Authors:  Andrew I R Scott; Linda D Sharples; Susan Stewart
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 7.  The pathology of heart and heart and lung transplantation--an update.

Authors:  S Stewart; N Cary
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

8.  T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis.

Authors:  S R Duncan; V Valentine; M Roglic; D J Elias; K W Pekny; J Theodore; D H Kono; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Current status of heart and lung transplantation.

Authors:  V A Starnes; S W Jamieson
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

10.  The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.

Authors:  Xiaoqin Hua; Tobias Deuse; Yi-Je Chen; Heike Wulff; Mandy Stubbendorff; Ralf Köhler; Hiroto Miura; Florian Länger; Hermann Reichenspurner; Robert C Robbins; Sonja Schrepfer
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.